ERBB2 and cancer: In TNBC and HER2-positive cancers, stromal TILs (sTILs) quantification demonstrated reproducibility and predicted longer survival [46,47,51]; however, the significance of the TILs in ER-positive, HER2-negative tumors remains uncertain [51,52].